Nina Cabezas-Wallscheid
Principal Investigator
Max Planck Institute of Immunobiology and Epigenetics (MPI-IE)
Stübeweg 51
79108 Freiburg
- +49 761 5108-530
- cabezas@ie-freiburg.mpg.de
- Homepage
Current position
Additional affiliation: Principal Investigator, Centre for Integrative Biological Signalling Studies (CIBSS), University of Freiburg
Academic training
| 2000 - 2005 | MSc Biotechnology, University of Barcelona, Spain and University of Parma, Italy |
Advanced academic qualifications
| 2010 | PhD, Laboratory of Molecular Mouse Genetics, Div. of Exp. and Translational Oncology, Medical Center of the Johannes Gutenberg University of Mainz |
Postgraduate Positions
| Since 2017 | Group Leader, MPI-IE, Freiburg |
| 2011 - 2017 | Postdoctoral fellow, Dept. of Stem Cells and Cancer, DKFZ, HI-STEM, Heidelberg |
| 05/10 - 12/10 | Postdoctoral bridge, Division of Exp. and Translational Oncology, Medical Center of the Johannes Gutenberg University of Mainz |
| 09-10/08 | Guest Scientist, Harvard Dept. of Stem Cell and Regenerative Biology, Boston, USA |
| 2006 - 2010 | PhD, Laboratory of Molecular Mouse Genetics, Division of Exp. and Translational Oncology, Medical Center of the Johannes Gutenberg University of Mainz |
Miscellaneous (Honors, Awards)
| 2019 | Josep Carreras Foundation Grant |
| 2019 | Visiting Assistant Professor Kumamoto University, Japan |
| 2018 | Behrens Weise Foundation |
| 2018 | Centre for Integrative Biological Signaling Studies (CIBSS) Excellence Cluster, University of Freiburg |
| 2018 | Marie Skłodowska-Curie Actions- Innovative Training Networks (MSCA-INT) |
| 2018 | Young Investigator Award, German Stem Cell Network (GSCN), Germany |
| 2018 | ERC Starting Grant, Freiburg, Germany |
| 2016 | New Investigator Postdoctoral Fellow Award, International Society Experimental Hematology (ISEH), San Diego, USA |
| 2015 | Young Investigator Fund NicHem; DFG Unit For 2033, Heidelberg, Germany |
| 2008 | Boehringer Ingelheim Foundation Travel Fellowship, Harvard Stem Cell Institute, Boston, USA |
| 2007 | PhD Fellowship, Mainzer Forschungsfond (MAIFOR), University of Mainz, Germany |
Publications listed in PubMed®
Publications (based on CRC1479 funding)
Schaffer AM, Fiala GJ, Hils M, Natali E, Babrak L, Herr LA, Romero-Mulero MC, Cabezas-Wallscheid N, Rizzi M, Miho E, Schamel WWA, Minguet S. Kidins220 regulates the development of B cells bearing the λ light chain. Elife. 2024 Jan 25;13:e83943. doi: 10.7554/eLife.83943.
Villa M, Sanin DE, Apostolova P, Corrado M, Kabat AM, Cristinzio C, Regina A, Carrizo GE, Rana N, Stanczak MA, Baixauli F, Grzes KM, Cupovic J, Solagna F, Hackl A, Globig AM, Hässler F, Puleston DJ, Kelly B, Cabezas-Wallscheid N, Hasselblatt P, Bengsch B, Zeiser R, Sagar, Buescher JM, Pearce EJ, Pearce EL. Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment. Nat Commun. 2024 Jan 11;15(1):451. doi: 10.1038/s41467-024-44689-2.Ho JNHG, Schmidt D, Lowinus T, Ryoo J, Dopfer EP, Gonzalo Núñez N, Costa-Pereira S, Toffalori C, Punta M, Fetsch V, Wertheimer T, Rittmann MC, Braun LM, Follo M, Briere C, Vinnakota JM, Langenbach M, Koppers F, Shoumariyeh K, Engel H, Rückert T, Märklin M, Holzmayer S, Illert AL, Magon F, Andrieux G, Duquesne S, Pfeifer D, Staniek J, Rizzi M, Miething C, Köhler N, Duyster J, Menssen HD, Boerries M, Buescher JM, Cabezas-Wallscheid N, Blazar BR, Apostolova P, Vago L, Pearce EL, Becher B, Zeiser R. Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation. Blood. 2022 Sep 8;140(10):1167-1181. doi: 10.1182/blood.2022016082.
Highlighted by this Editorial: Bleakley M, Biernacki M. MDM2 inhibition augments GVL effect. Blood. 2022 Sep 8;140(10):1064-1065. doi: 10.1182/blood.2022017724. PMID: 36074535.
Zhang YW, Mess J, Aizarani N, Mishra P, Johnson C, Romero-Mulero MC, Rettkowski J, Schönberger K, Obier N, Jäcklein K, Woessner NM, Lalioti ME, Velasco-Hernandez T, Sikora K, Wäsch R, Lehnertz B, Sauvageau G, Manke T, Menendez P, Walter SG, Minguet S, Laurenti E, Günther S, Grün D, Cabezas-Wallscheid N. Hyaluronic acid-GPRC5C signalling promotes dormancy in haematopoietic stem cells. Nat Cell Biol. 2022 Jul;24(7):1038-1048. doi: 10.1038/s41556-022-00931-x. Epub 2022 Jun 20.
Schönberger K, Mitterer M, Buescher JM, Cabezas-Wallscheid N. Targeted LC-MS/MS-based metabolomics and lipidomics on limited hematopoietic stem cell numbers. STAR Protoc. 2022 May 19;3(2):101408. doi: 10.1016/j.xpro.2022.101408.
Spohr C, Poggio T, Andrieux G, Schönberger K, Cabezas-Wallscheid N, Boerries M, Halbach S, Illert AL, Brummer T. Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo. Leukemia. 2022 Apr;36(4):970-982. doi: 10.1038/s41375-021-01490-0. Epub 2021 Dec 13.2021
Contact
